ARAK, H.; KUŞ, T. Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy. European Journal of Therapeutics, [S. l.], 2024. DOI: 10.58600/eurjther2151. Disponível em: https://eurjther.com/index.php/home/article/view/2151. Acesso em: 30 jun. 2024.